Cargando…

Recombinant vaccines for COVID-19

SARS-CoV-2, the causative agent of COVID-19, has imposed a major public health threat, which needs effective therapeutics and vaccination strategies. Several potential candidate vaccines being rapidly developed are in clinical evaluation. Considering the crucial role of SARS-CoV-2 spike (S) glycopro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Tushar, Srivastava, Nishant, Mishra, Gourav, Dhama, Kuldeep, Kumar, Swatantra, Puri, Bipin, Saxena, Shailendra K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711739/ https://www.ncbi.nlm.nih.gov/pubmed/33232211 http://dx.doi.org/10.1080/21645515.2020.1820808

Ejemplares similares

Tracking the COVID-19 vaccines: The global landscape
por: Yadav, Tushar, et al.
Publicado: (2023)

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
por: Dhama, Kuldeep, et al.
Publicado: (2020)

Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
por: Saxena, Shailendra K., et al.
Publicado: (2020)

COVID-19: benefits and risks of passive immunotherapeutics
por: Gupta, Ankur, et al.
Publicado: (2020)

Fabrication and Evaluation of Basil Essential Oil-Loaded Halloysite Nanotubes in Chitosan Nanocomposite Film and Its Application in Food Packaging
por: Chaudhary, Narayan, et al.
Publicado: (2022)

Exploring the possible use of saponin adjuvants in COVID-19 vaccine
por: Sharma, Rinku, et al.
Publicado: (2020)

BCG vaccine: a hope to control COVID-19 pandemic amid crisis
por: Malik, Yashpal Singh, et al.
Publicado: (2020)

Recent advances in vaccine and immunotherapy for COVID-19
por: Rabaan, Ali A., et al.
Publicado: (2020)

COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
por: Dhama, Kuldeep, et al.
Publicado: (2022)

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic
por: Barbuddhe, Sukhadeo Baliram, et al.
Publicado: (2020)

Therapeutic approaches for SARS-CoV-2 infection
por: Gupta, Ankur, et al.
Publicado: (2021)

Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection
por: Padhi, Abhishek, et al.
Publicado: (2020)

Environmental Health Risks After the 2023 Turkey-Syria Earthquake and Salient Mitigating Strategies: A Critical Appraisal
por: Ahmed, Sirwan Khalid, et al.
Publicado: (2023)

Therapeutic Development and Drugs for the Treatment of COVID-19
por: Maurya, Vimal K., et al.
Publicado: (2020)

Structural and molecular perspectives of SARS-CoV-2
por: Kumar, Swatantra, et al.
Publicado: (2021)

Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19
por: Kumar, Swatantra, et al.
Publicado: (2022)

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview
por: Dagnew, Alemnew F., et al.
Publicado: (2021)

Influence of COVID-19 vaccines on endocrine system
por: Zhao, Ying, et al.
Publicado: (2022)

Global Trends in Epidemiology of Coronavirus Disease 2019 (COVID-19)
por: Srivastava, Nishant, et al.
Publicado: (2020)

COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic
por: Sharun, Khan, et al.
Publicado: (2021)

COVID-19: comprehensive review on mutations and current vaccines
por: Hebbani, Ananda Vardhan, et al.
Publicado: (2021)

Landscape and progress of global COVID-19 vaccine development
por: Huang, Hui-Yao, et al.
Publicado: (2021)

An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines
por: Kale, Akanksha, et al.
Publicado: (2023)

COVID-19 vaccine development from the perspective of cancer patients
por: He, Yang, et al.
Publicado: (2021)

Adverse events and preventive measures related to COVID-19 vaccines
por: Ahn, Tae Kyu, et al.
Publicado: (2021)

Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update
por: Hernández-Díazcouder, Adrián, et al.
Publicado: (2023)

Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
por: Iqbal Yatoo, Mohd., et al.
Publicado: (2021)

Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19)
por: Baghban, Roghayyeh, et al.
Publicado: (2023)

Prolactin and cancer: Has the orphan finally found a home?
por: Sethi, Bipin Kumar, et al.
Publicado: (2012)

Advances in recombinant antibody manufacturing
por: Kunert, Renate, et al.
Publicado: (2016)

Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19
por: Mosaddeghi, Pouria, et al.
Publicado: (2020)

Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines
por: Altrichter, Sabine, et al.
Publicado: (2021)

Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review
por: Yeo, Suji, et al.
Publicado: (2023)

Current Insight into the Novel Coronavirus Disease 2019 (COVID-19)
por: Saxena, Shailendra K., et al.
Publicado: (2020)

Prevention and Control Strategies for SARS-CoV-2 Infection
por: Srivastava, Nishant, et al.
Publicado: (2020)

Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2
por: Bilal, Muhammad, et al.
Publicado: (2020)

Insights into epigenetic landscape of recombination-free regions
por: Termolino, Pasquale, et al.
Publicado: (2016)

Prevention of unwanted recombination at damaged replication forks
por: Lehmann, Carl P., et al.
Publicado: (2020)

Correction to: Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r5lhgkuoohkhqcbrkapvv8m467